These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28990485)

  • 1. There is a need for new systemic sclerosis subset criteria. A content analytic approach.
    Johnson SR; Soowamber ML; Fransen J; Khanna D; Van Den Hoogen F; Baron M; Matucci-Cerinic M; Denton CP; Medsger TA; Carreira PE; Riemekasten G; Distler J; Gabrielli A; Steen V; Chung L; Silver R; Varga J; Müller-Ladner U; Vonk MC; Walker UA; Wollheim FA; Herrick A; Furst DE; Czirjak L; Kowal-Bielecka O; Del Galdo F; Cutolo M; Hunzelmann N; Murray CD; Foeldvari I; Mouthon L; Damjanov N; Kahaleh B; Frech T; Assassi S; Saketkoo LA; Pope JE
    Scand J Rheumatol; 2018 Jan; 47(1):62-70. PubMed ID: 28990485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification criteria for systemic sclerosis subsets.
    Johnson SR; Feldman BM; Hawker GA
    J Rheumatol; 2007 Sep; 34(9):1855-63. PubMed ID: 17696271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the clinical classification of systemic sclerosis.
    Johnson SR
    Curr Opin Rheumatol; 2017 Nov; 29(6):568-573. PubMed ID: 28961157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets.
    Nevskaya T; Pope JE; Turk MA; Shu J; Marquardt A; van den Hoogen F; Khanna D; Fransen J; Matucci-Cerinic M; Baron M; Denton CP; Johnson SR
    J Rheumatol; 2021 Nov; 48(11):1698-1717. PubMed ID: 33993109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying the ACR/EULAR Systemic Sclerosis Classification Criteria to the Spanish Scleroderma Registry Cohort.
    Sáez-Comet L; Simeón-Aznar CP; Pérez-Conesa M; Vallejo-Rodríguez C; Tolosa-Vilella C; Iniesta-Arandia N; Colunga-Argüelles D; Egurbide-Arberas MV; Ortego-Centeno N; Vargas-Hitos JA; Freire-Dapena M; Rubio-Rivas M; Ríos-Blanco JJ; Trapiella-Martínez L; Fonollosa-Pla V;
    J Rheumatol; 2015 Dec; 42(12):2327-31. PubMed ID: 26472418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival.
    Fernández-Codina A; Simeón-Aznar CP; Pinal-Fernandez I; Rodríguez-Palomares J; Pizzi MN; Hidalgo CE; Guillén-Del Castillo A; Prado-Galbarro FJ; Sarria-Santamera A; Fonollosa-Plà V; Vilardell-Tarrés M
    Rheumatol Int; 2017 Jan; 37(1):75-84. PubMed ID: 26497313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
    van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
    Ann Rheum Dis; 2013 Nov; 72(11):1747-55. PubMed ID: 24092682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis sine scleroderma.
    Kucharz EJ; Kopeć-Mędrek M
    Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous and serologic subsets of systemic sclerosis.
    Ferri C; Bernini L; Cecchetti R; Latorraca A; Marotta G; Pasero G; Neri R; Bombardieri S
    J Rheumatol; 1991 Dec; 18(12):1826-32. PubMed ID: 1795320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis: To subset or not to subset, that is the question.
    Johnson SR; van den Hoogen F; Devakandan K; Matucci-Cerinic M; Pope JE
    Eur J Rheumatol; 2020 Oct; 7(Suppl 3):S222-S227. PubMed ID: 33164736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of systemic sclerosis in a district of northern Italy.
    Lo Monaco A; Bruschi M; La Corte R; Volpinari S; Trotta F
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S10-4. PubMed ID: 21586212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.